Cardio-Phoenix News & Updates

Explore our latest announcements, insights, event highlights, published research, and real-world use cases of Cardio-HART.

Use Case
Myocardial infarction in question
November 1, 2022
Situation A 54-year-old male patient has a previous (a month earlier) normal ECG, and the physician did not diagnose any problem. CHART test is…
Read More
Publications
Detecting Heart Failure using novel bio-signals and a Knowledge Enhanced Neural Network
October 27, 2022
Background Clinical decisions about Heart Failure (HF) are frequently based on measurements of left ventricular ejection fraction (LVEF), relying mainly on echocardiography measurements for evaluating structural…
Read More
Publications
Unraveling diagnostic co-morbidity makeup of each HF category as characteristically derived by ECG- and ECHO-findings
October 24, 2022
Background Echocardiography (ECHO) is not widely available in primary care, the key structural (chamber enlargements) and functional abnormality are not easily available precluding the ability…
Read More
Use Case
Pacemaker patient assessment with CHART
October 20, 2022
Situation Female patient with a previous history of carcinoma and mildly decreased systolic function due to cardiotoxicity. She had a previous heart trauma and a…
Read More
Events
HETT Show 2022 – Interview with Marc
October 4, 2022
The HETT show 2022 has been successfully finished for Cardio-Phoenix Company. We spoke with Marc, CEO and Founder of Cardio-Phoenix, about the experience and expectations after…
Read More
Events
Cardio-Heart at HETT Show 2022
September 16, 2022
Our team at Cardio-Phoenix is excited to announce that we will be exhibiting at the Healthcare Excellence Through Technology (HETT Show) on 27-28 September 2022.…
Read More

Categories

What makes Cardio-HART a game-changer in early cardiac diagnostics?

Cardio-HART redefines how heart conditions are detected by combining advanced biosignal analysis with AI. Instead of relying solely on ECG, it captures a deeper view of the heart’s mechanical and electrical functions — enabling primary care physicians to detect complex heart diseases earlier, without waiting for specialist referrals.

How does Cardio-HART differ from traditional ECG in real-world studies?

Unlike ECG, Cardio-HART uses AI-driven algorithms combining ECG, PCG, and MCG signals to detect structural and functional heart disorders with higher sensitivity — as validated in multiple studies.

Where has Cardio-HART been presented or featured?

Cardio-HART has been presented at major European cardiology congresses and scientific publications. See our Events and Publications sections for more.

FAQ –>